measuregroup/AID1798074

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID49689430_AID1798074_PMID17948978_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID49689430_AID1798074_PMID17948978_VALUE6 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID49689430_AID1798074_PMID17948978_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID49689430_AID1798074_PMID17948978_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID49689430_AID1798074_PMID17948978_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID49689430_AID1798074_PMID17948978_VALUE2
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP10635 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33261 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11509 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11712 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP05177 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08684
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title	Cytochrome P450 Inhibition from Article 10.1021/jm070521y: \"Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist.\"
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID49689430
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1798074

Total number of triples: 17.